The
Rosellinia sanctae
-
cruciana
extract was subjected to detailed liquid
chromatography tandem mass
spectrometry studies. A total of 38 peaks were annotated to
m
/
z
508.26,
m
/
z
510.28,
m
/
z
524.26,
m
/
z
526.28,
m
/
z
540.26,
m
/
z
542.27,
and
m
/
z
584.28 [M + H]
+
. The accurate mass, mutually supported UV/vis spectra, and database
search identified these compounds as cytochalasins. Systematic dereplication
helped identify a peak at
m
/
z
540.26
[M + H]
+
as the new compound. Further, the identified compound
was purified by high-performance liquid chromatography and characterized
by 2D NMR to be 19,20-epoxycytochalasin N1, a new optical isomer of
19,20-epoxycytochalasin-N. It exhibited substantial cytotoxicity with
IC
50
values ranging from 1.34 to 19.02 μM. This study
shows a fast approach for dereplicating and identifying novel cytochalasin
metabolites in crude extracts.